Abstract: The invention provides methods and materials related to the treatment of inflammation. Such inflammations include, without limitation, those inflammations mediated by eosinophils and/or neutrophils as well as those inflammations associated with peroxidase activity. The invention also provides methods and materials related to the treatment of complications associated with eosinophil-mediated inflammations and/or neutrophil-mediated inflammations. Specifically, the invention involves increasing the amount of pseudohalides in a mammal exhibiting inflammation and/or an associated condition.